07:00 , Apr 9, 2009 |  BC Innovations  |  Distillery Therapeutics

This week in therapeutics

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Metabolic disease Obesity Component 3a receptor 1 (C3AR1); transforming growth factor-b receptor II (TGFBR2); growth arrest-specific gene 7 (GAS7); glutathione peroxidase...
07:00 , Apr 9, 2009 |  BC Innovations  |  Cover Story

Opening up Rosetta

Merck & Co. Inc. 's soon-to-be shuttered Rosetta Inpharmatics Inc. unit is to be reborn as Sage , a not-for-profit institute that aims to provide precompetitive open access to the pharma's integrative genomics data set....